- Cell Line
- Animal Genome
- Plant Genome
Genetic Engineering Market size was valued at USD 4.8 billion in 2022 and is poised to grow at a significant CAGRof 15.55% during the forecast period 2023-2029. The alteration of genes in an organism or species to improve its skills is known as genetic engineering. Pharmaceutical and biotechnology firms, as well as clinical research institutions, utilise the technology. Gene therapy is the most extensively utilised therapeutic method for cancer and other infectious disorders in medicine. Genetic engineering Market alludes to the set of technologies that directly manipulate on an organism's genes, change the genetic makeup of cells and add one or more new traits that are not found in that organism. At the core of all life is the thing that we call DNA. It is in charge of the plenitude of life on this Earth and the motivation behind why we are how we are. The hereditary make-up of any creature is characterized by DNA. In nature, the genetic nature never stays settled. Biotech and pharma sectors dominating the Genetic Engineering Market industry owing to several applications in drug discovery and therapeutics. With the increase in the use of CRISPR and ZFN, companies are capitalizing on innovative researches focusing on the development of editing techniques. For example, the introduction of an initiative called the Artemisinin Project is planning to use synthetic biology to help treat malaria. Key strategies implemented by industry players include mergers and acquisitions, strategic collaborations for R&D outsourcing or manufacturing activities are driving the market growth of genome editing.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increasing prevalence of cancer and other genetic disorders, growing preference for personalized medicine, Increase in R&D expenditure and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and genetic engineering technologies, applications in various drug discovery processes are some of the factors propelling the growth of the genetic engineering market. Moreover, Global genetic engineering market may be hindered by stringent government regulations for approval to gene mutation projects, ethical issues, unavailability of gene based therapeutics in the market and lack of awareness among people regarding the safety of genetic interventions.
North America
Europe
Asia-Pacific
Latin America
Middle East and Africa (MEA)
Increasing number of genetic disorders.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
1.Executive Summary |
2.Global Genetic Engineering Market Introduction |
2.1.Global Genetic Engineering Market - Taxonomy |
2.2.Global Genetic Engineering Market - Definitions |
2.2.1.Type |
2.2.2.Technique |
2.2.3.End User |
2.2.4.Region |
3.Global Genetic Engineering Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Genetic Engineering Market Analysis, 2018-2022 and Forecast 2023-2029 |
4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Genetic Engineering Market By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
5.1. Cell Line |
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Animal Genome |
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Plant Genome |
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Genetic Engineering Market By Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
6.1. Artificial Selection |
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Cloning |
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Gene Splicing |
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Others |
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
7.Global Genetic Engineering Market By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
7.1. Pharmaceutical companies |
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Biotechnology Companies |
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Academics |
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Clinical Research Organizations |
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
8.Global Genetic Engineering Market By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9.North America Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
9.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Cell Line |
9.1.2.Animal Genome |
9.1.3.Plant Genome |
9.2. Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Artificial Selection |
9.2.2.Cloning |
9.2.3.Gene Splicing |
9.2.4.Others |
9.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.Pharmaceutical companies |
9.3.2.Biotechnology Companies |
9.3.3.Academics |
9.3.4.Clinical Research Organizations |
9.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10.Europe Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Cell Line |
10.1.2.Animal Genome |
10.1.3.Plant Genome |
10.2. Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Artificial Selection |
10.2.2.Cloning |
10.2.3.Gene Splicing |
10.2.4.Others |
10.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Pharmaceutical companies |
10.3.2.Biotechnology Companies |
10.3.3.Academics |
10.3.4.Clinical Research Organizations |
10.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11.Asia Pacific (APAC) Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Cell Line |
11.1.2.Animal Genome |
11.1.3.Plant Genome |
11.2. Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Artificial Selection |
11.2.2.Cloning |
11.2.3.Gene Splicing |
11.2.4.Others |
11.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Pharmaceutical companies |
11.3.2.Biotechnology Companies |
11.3.3.Academics |
11.3.4.Clinical Research Organizations |
11.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12.Middle East and Africa (MEA) Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Cell Line |
12.1.2.Animal Genome |
12.1.3.Plant Genome |
12.2. Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Artificial Selection |
12.2.2.Cloning |
12.2.3.Gene Splicing |
12.2.4.Others |
12.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Pharmaceutical companies |
12.3.2.Biotechnology Companies |
12.3.3.Academics |
12.3.4.Clinical Research Organizations |
12.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13.Latin America Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million) |
13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Cell Line |
13.1.2.Animal Genome |
13.1.3.Plant Genome |
13.2. Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Artificial Selection |
13.2.2.Cloning |
13.2.3.Gene Splicing |
13.2.4.Others |
13.3. End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Pharmaceutical companies |
13.3.2.Biotechnology Companies |
13.3.3.Academics |
13.3.4.Clinical Research Organizations |
13.4. Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Thermo Fisher Scientific Inc. (US) |
14.2.2.Merck KGaA (Germany) |
14.2.3.Horizon Discovery Group Plc. (UK) |
14.2.4.Transposagen Biopharmaceuticals Inc. (US) |
14.2.5.New England Biolabs (U.S) |
14.2.6.Genscript Biotech Corporation (US) |
14.2.7.Lonza Group Ltd. (Switzerland) |
14.2.8.Origene Technologies, Inc. (US) |
14.2.9.Integrated DNA Technologies, Inc. (US) |
14.2.10.Amgen Inc.(US) |
14.2.11.Genentech, Inc. (US) |
14.2.12.Sangamo Therapeutics, Inc. (US) |
15. Research Methodology |
16. Appendix and Abbreviations |